Abnormal serum uric acid levels in children (Q40997371)

25 September 2017

1 reference

title

Abnormal serum uric acid levels in children (English)

1 reference

25 September 2017

Wilcox WD

1

1 reference

PubMed ID

8648529

25 September 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

The Journal of Pediatrics

25 September 2017

1 reference

25 September 2017

128

1 reference

25 September 2017

6

1 reference

25 September 2017

731-741

1 reference

Influence of the kidney upon urate homeostasis in health and disease

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

The contribution of residual nephrons within the chronically diseased kidney to urate homeostasis in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Uric acid excretion in normal children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

The renal mechanism for urate homeostasis in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Uric acid metabolism in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Intrinsic Renal Disease Leading to Abnormal Urate Excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Origin and Extrarenal Elimination of Uric Acid in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Uric acid levels in full-term and low-birth-weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Plasma uric acid levels in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

THE DISTRIBUTION OF SERUM URIC ACID VALUES IN A POPULATION UNSELECTED AS TO GOUT OR HYPERURICEMIA: TECUMSEH, MICHIGAN 1959-1960

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Normal serum uric acid concentrations for age and sex and incidence of renal hypouricaemia in Japanese school children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Gout, uric acid and purine metabolism in paediatric nephrology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Uric acid homeostasis in lean and obese girls during pubertal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Effect of oestrogen therapy on plasma and urinary levels of uric acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Uric Acid Excretion: Quantitative Assessment from Spot, Midmorning Serum and Urine Samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

A screening test for hyperuricosuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Uric acid nephrolithiasis in gout. Predisposing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Investigation of metabolic disorders resembling Reye's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Adult Reye's syndrome: a review with new evidence for a generalized defect in intramitochondrial enzyme processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hyperuricemia in Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Uric acid metabolism in psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Sickle Cell Anemia and Hyperuricemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

The Natural History of Urate Overproduction in Sickle Cell Anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hyperuricemia in congenital heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hyperuricemia in an infant with Taussig-Bing anomaly and interruption of the aortic arch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Impairment of urate excretion in patients with cardiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Renal function in children undergoing cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Iatrogenic hyperuricemia in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hypoxanthine-guanine phosphoribosyltransferase variants: correlation of clinical phenotype with enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Plasma and urinary oxypurines in Lesch-Nyhan patient after allopurinol treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Serial renal sonographic evaluation of patients with Lesch-Nyhan syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Failure to thrive, hyperuricemia, and renal insufficiency in early infancy secondary to partial hypoxanthine-guanine phosphoribosyl transferase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

A missense mutation in the hypoxanthine phosphoribosyltransferase gene in a pediatric patient with hyperuricemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

A new disorder of purine metabolism with behavioral manifestations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

An X-linked syndrome characterised by hyperuricaemia, deafness, and neurodevelopmental abnormalities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Distinct neurological syndrome in two brothers with hyperuricaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Long-term course of neonatal diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Myoadenylate deaminase deficiency: inherited and acquired forms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Molecular analysis of the myoadenylate deaminase deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

ATP Depletion, a Possible Role in the Pathogenesis of Hyperuricemia in Glycogen Storage Disease Type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Glycogenosis type V (McArdle's disease) with hyperuricemia. A case report and clinical investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Stimulation of human purine synthesis de novo by fructose infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Transient organic aciduria and persistent lacticacidemia in a patient with short-chain acyl-coenzyme A dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Neonatal onset of medium-chain acyl-coenzyme A dehydrogenase deficiency with confusing biochemical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hyperuricemia in medium-chain acyl-coenzyme A dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Renal Pathogenesis of Familial Hyperuricemia: Studies in Two Kindreds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Factors affecting urate excretion following diuretic administration in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hyperuricemia in diarrheal dehydration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hyperuricemia in the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

The hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Maple syrup urine disease 1954 to 1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Nephropathy in Chronic Lead Poisoning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Renal function and histopathologic changes in children after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Uric acid in childhood essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Plasma uric acid in patients receiving anticonvulsant monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Xanthine-containing calculi during allopurinol therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Urinary Xanthine Stones-a Rare Complication of Allopurinol Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

The Clinical Significance of Hypouricemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Xanthinuria in a Large Kindred

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Xanthinuria: An Additional Case with Demonstration of Xanthine Oxidase Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Normal uric acid concentrations in a purine nucleoside phosphorylase (PNP) deficient child presenting with severe chicken pox, possible immunodeficiency and developmental delay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

The Fanconi syndrome and mechanisms of tubular transport dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Human renal Fanconi syndrome--then and now

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Renal urate excretion in patients with Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Familial renal hypouricemia with intact reabsorption of uric acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Familial hypouricaemia due to an isolated tubular defect of urate reabsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Familial hypouricemia due to isolated renal tubular defect. Attenuated response of uric acid clearance to probenecid and pyrazinamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Familial Renal Hypouricaemia: Two Additional Cases with Uric Acid Lithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Acute renal failure after exercise in a child with renal hypouricaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hypouricemia in Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Diabetic renal hypouricemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Xanthine calculi in the Lesch-Nyhan syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

Optimal management of acute toxicities of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970322-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(96)70322-0

1 reference

25 September 2017

1 reference

PubMed ID

8648529